Interestingly, application of an anti-NCL antibody not only attenuated the basal ECAR but also completely abrogated the HDGF-stimulated ECAR in hepatoma cells (Fig. 6D). This evidence concerns the gene NUCLEOLIN and hepatocellular carcinoma.